Magdalena Blaszkiewicz, Ph.D. is co-founder and CEO of Neuright, Inc. She holds a doctorate in biomedical science from University of Maine and has over 10 years prior experience in a biomedical start-up in Boston. Blaszkiewicz attended the Biotech Masters program at Harvard Extension School, and her pitch won the Maine Center for Entrepreneurs 2019 Top Gun competition along with a $25,000 prize from the David E. Shaw Family Foundation. Blaszkiewicz was PI of the NSF Phase 1 STTR. Dr. Blaskiewicz is now Senior Research Scientist at The Ohio State University's Department of Neurological Surgery
Kristy Townsend, Ph.D. is co-founder, Chief Scientific Officer (CSO) and Chair of the Board for Neuright, Inc. Former Associate Professor of Neurobiology at UMaine, and now Associate Professor in the Department of Neurological Surgery at Wexner Medical Center, The Ohio State University, and is an expert in peripheral nerves, neuropathy, diabetes, obesity, and the brain’s control of energy balance and metabolic health. Townsend holds a doctorate in Neuroscience from Boston University, and is passionate about ethical and transparent biotech commercialization. Learn more at ktownsendlab.com.
Derek Houtman is CFO and COO of Neuright, Inc. He has more than 15 years experience in sales, financial management, and business operations. In his previous positions, Houtman oversaw teams of more than 30 employees, and he was responsible for hiring, training, and supervising personnel, as well as managing a regional team with over $350mm sales annually, working with suppliers and supply chain dynamics, merchandizing, and reporting and analyzing sales. Houtman brings other experience in retail consulting, as well as procurement and purchasing for University systems. Currently, Houtman oversees personnel, finances, and laboratory management for Neuright, and as manufacturing lead and engineering liaison, is ensuring the ‘DEN’ diagnostic device can be manufactured in an FDA-compliant way for human testing and clinical trials by maintaining and overseeing the design history file and device design specs.
Science and Engineering Collaborators
Rosemary Smith, Ph.D. is the lead biomedical engineer for the design and fabrication of Neuright’s MVP product, Detecting Early Neuropathy (DEN). Smith is a Professor of Electrical and Computer Engineering at UMaine, and is an expert in microfabrication and microneedle design.
Leonard Kass, Ph.D. is Neuright’s neuroscience and electrophysiology collaborator, and is an Associate Professor of Biological Sciences at University of Maine.
Nuri Emanetoglu, Ph.D. is an Associate Professor of Electrical and Computer Engineering at University of Maine and an expert in sensors, electrical signal optimization, and wireless electronics.
Ali Abedi, Ph.D. is a Professor of Electrical and Computer Engineering and an expert at computational signal analysis and wireless communication. He is co-founder of Activas Diagnostics, another UMaine spin-off company.
External Advisory Board
- Robert Maxwell VP of Growth, RodeoCPG
- Kathy Robinson, Founder/President, TurningPoint Boston
- Prof. Marie Hayes, Co-founder, CEO/CSO Activas Diagnostics
- George Sass Jr. Managing Director, Blue Creative Group
Collaborating and Consulting Physicians: